Health Care/Hospital

Asia's Leading Companies Celebrated at the 2019 Frost & Sullivan Asia-Pacific Best Practices Awards

SINGAPORE, June 7, 2019 /PRNewswire/ -- Frost & Sullivan named some of Asia's leading companies recognized for their achievements in its recipients list for the Asia-Pacific Best Practices Awards earlier today. Mr. Shivaji Das, Partner & Asia-Pacific Managing Director at Frost & Sullivan noted t...

2019-06-07 23:23 5162

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal l...

2019-06-06 18:00 15314

HealthEngine celebrates new milestone for Australian health, recording one million bookings in a single month

PERTH, Australia, June 6, 2019 /PRNewswire/ -- HealthEngine has solidified its position as Australia's leading consumer healthcare platform, reaching one million monthly bookings in May 2019. CEO and Medical Dir...

2019-06-06 09:21 4516

Yichun to boost tourism industry development in Jiangxi

YICHUN, China, June 5, 2019 /PRNewswire/ -- The 2019 Jiangxi Tourism Industry Development Conference opened in Yichun City, East China'sJiangxi province on June 5. The annual event is an important platform for tourism cooperation of Jiangxi Province. Yichun, one of the most picturesque citi...

2019-06-05 18:31 2875

Poor Oral Health Severely Impacts Training and Athletic Performance, Says FDI World Dental Federation

GENEVA, June 5, 2019 /PRNewswire/ -- If they want to win, elite and amateur athletes need to make theiroral health a top priority. FDI World Dental Federation (FDI) couldn't agree more. Today the organization released a serie...

2019-06-05 09:00 2000

Innovent provides Update on the Results of Sintilimab for the Treatment of Extranodal NK/T Cell Lymphoma by Oral Presentation at ASCO

SUZHOU, China, June 5, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the research data on the treatment of relapsed or refractory extranodal NK/T cell ly...

2019-06-05 08:00 4876

Cellenkos, Inc. Initiates Phase 1 Clinical Trial of CK0801 for Treatment of Bone Marrow Failure Syndromes

HOUSTON, June 4, 2019 /PRNewswire/ -- Cellenkos, Inc., announced today the initiation of a Phase 1 Clinical Trial of CK0801, a first-in-class, allogeneic cord blood-derived T-regulatory cell product, for treatment of patients with bone marrow failure syndromes, including aplastic anemia, hypoplas...

2019-06-04 21:17 4847

RemeGen, Ltd. Announces Positive Results from RC48 Clinical Trial in HER2-Positive Metastatic or Unresectable Urothelial Cancer

Results, presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, demonstrated clinically meaningful response in patients with urothelial carcinoma whose treatment previously failed, a population with high unmet medical need YANTAI, China, June 4, 2019 /PRNewswire/ -- R...

2019-06-04 21:00 4648

Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company

HONG KONG, June 4, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors has received a no...

2019-06-04 20:17 16238

Medtec China will expand to 2 Halls in 2020 for the first time

SHANGHAI, June 4, 2019 /PRNewswire/ -- Medtec China 2019 will be held at Shanghai World Expo Exhibition and Convention Center September 25–27. This exhibition has continued its upward momentum trend -- the overall scale of the event is up by21%, and the area of exhibition booths commercially avai...

2019-06-04 19:11 4638

Genecare partners with Jupiter Chain to release a secure online genetic profiling platform

SINGAPORE, June 4, 2019 /PRNewswire/ -- Genetics testing is the core of preventive healthcare. Clients must first understand their genetic makeup to lower the risks of developing an illness or disease. A leading ASEAN company, Genecare, is one genetics testing company that allows clients to bette...

2019-06-04 09:00 2778

Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical Hodgkin's Lymphoma

SUZHOU, China, June 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the results of extended follow-up on sintilimab, the anti-PD-1 antibody that co-deve...

2019-06-04 08:00 9021

Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC)

SUZHOU, China, June 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the preliminary results of efficacy and safety of sintilimab, the anti-PD-1 antibody...

2019-06-04 08:00 9030

Innovent Provides Update on ctDNA in Predicting Response and Resistance by Anti-PD-1 Therapy in Chinese Relapsed/Refractory Classical Hodgkin Lymphoma

SUZHOU, China, June 3, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the results of circulating tumor DNA (ctDNA) for predicting response and resistance ...

2019-06-04 08:00 2554

Merck Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical Response in Patients with Advanced NSCLC with METex14 Skipping Mutations

ASCO Abstract # Tepotinib (MET kinase inhibitor): 9005 Not intended for UK- , Canada- or US-based media DARMSTADT, Germany, June 4, 2019 /PRNewswire/ -- * Alterations of the MET signaling pathway are present in 3-5% of non-small cell lung cancer patients and correlate with poor prognosis * N...

2019-06-04 02:16 2244

IMG Announces Start of Annual Leave Your Mark Essay Contest

INDIANAPOLIS, June 4, 2019 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning, global insurance benefits and assistance services company is pleased to announce the start of their third annual Leave Your Mark essay contest, designed to benefit mission organizations around the wo...

2019-06-04 01:02 1460

Frost & Sullivan Publishes Q1 Update on Kadimastem

Continues its plans as expected; Ministry of Health approval for central experiment; financing is required to continue operations at the beginning of 2020; received Orphan Drug Designation from the FDA; target price unchanged. TEL AVIV, Israel, June 3, 2019 /PRNewswire/ -- The TASE analysis proje...

2019-06-03 21:24 1322

Oxitec Successfully Completes First Field Deployment of 2nd Generation Friendly™ Aedes aegypti Technology

- First field trial achieved up to 96% suppression of target disease-transmitting mosquito populations in dense urban settings inBrazil - Results indicate an increase in cost effectiveness over the 1st Generation with limited production requirements CAMPINAS, Brazil, June 3, 2019 /PRNewswire/ -...

2019-06-03 20:30 6700

International Medical Innovation and Cooperation Forum held in Fangchenggang City

FANGCHENGGANG, China, June 3, 2019 /PRNewswire/ -- As reported by CRI Online: Recently, the International Medical Innovation and Cooperation Forum (China-Shanghai Cooperation Organization), co-sponsored by the Shanghai Cooperation Organization Good-Neighborly Friendship and Cooperation Committee ...

2019-06-03 19:43 2390

Updated Results on Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Squamous Non-Small Cell Lung Cancer (sqNSCLC) at ASCO, Led by Professor Jie He, Dean of the Cancer Hospital of the Chinese Academy of Medical Sciences

SUZHOU, China, June 3, 2019 /PRNewswire/ -- The preliminary results of efficacy and safety of neoadjuvant PD-1 blockade with sintilimab in resectable squamous non-small cell lung cancer (sqNSCLC) (ChiCTR-OIC-17013726), led by ProfessorJie He, Dean of the Cancer Hospital of the Chinese Academy of ...

2019-06-03 08:00 10867
1 ... 223224225226227228229 ... 419